Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens

Journal of Infectious Diseases

Volumn 210, Issue 7, 2014, Pages 1123-1132

  Ondigo, Bartholomew N ^a,b   Hodges, James S ^c   Ireland, Kathleen F ^d   Magak, Ng'wena G ^a   Lanar, David E ^b   Dutta, Sheetij ^b   Narum, David L ^e   Park, Gregory S ^f   Ofulla, Ayub V ^f   John, Chandy C ^b,d  

^a MASENO UNIVERSITY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Walter Reed Army Institute for Research   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antibody; Elimination; Half life; Malaria; Plasmodium falciparum

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIBODY; PARASITE ANTIGEN; PLASMODIUM FALCIPARUM ANTIBODY; PLASMODIUM FALCIPARUM ANTIGEN; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMETRIC BEAD ASSAY; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INFANT; INFECTION SENSITIVITY; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEROCONVERSION; AGE; BLOOD; IMMUNOLOGY; MALARIA, FALCIPARUM; MIDDLE AGED; PRESCHOOL CHILD; TIME; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOASSAY; INFANT; KENYA; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; TIME FACTORS; YOUNG ADULT;

EID: 84922394090     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu225     Document Type: Article

References (39)

1. WHO. WHO World Malaria Report. Geneva, 2012.
2. Drakeley CJ, Corran PH, Coleman PG, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 2005;102:5108-13.
3. Bousema T, Youssef RM, Cook J, et al. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis 2010;16:392-9.
4. Cook J, Reid H, Iavro J, et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J 2010;9:169.
5. Akpogheneta OJ, Duah NO, Tetteh KK, et al. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 2008;76:1748-55.
6. Reddy SB, Anders RF, Beeson JG, et al. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLOS One 2012;7:e32242.
7. McCarra MB, Ayodo G, Sumba PO, et al. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. Pediatr Infect Dis J 2011;30:1037-42.
8. Dodoo D, Atuguba F, Bosomprah S, et al. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Malar J 2011;10:108.
9. Courtin D, Oesterholt M, Huismans H, et al. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLOS One 2009;4:e7590.
10. Stanisic DI, Richards JS, McCallum FJ, et al. Immunoglobulin G subclassspecific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 2009;77:1165-74.
11. Giha HA, Staalsoe T, Dodoo D, et al. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol Lett 2000;71:117-26.
12. Sarr JB, Remoue F, Samb B, et al. Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. Malar J 2007;6:117.
13. John CC, McHugh MM, Moormann AM, Sumba PO, Ofulla AV. Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya. Trans R Soc Trop Med Hyg 2005;99:780-6.
14. Menge DM, Ernst KC, Vulule JM, Zimmerman PA, Guo H, John CC. Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area. Am J Trop Med Hyg 2008;79:173-7.
15. Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993;61:315-20.
16. Ondigo BN, Park GS, Gose SO, et al. Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens. Malar J 2012;11:427.
17. John CC, Moormann AM, Pregibon DC. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am J Trop Med Hyg 2005;73:222-8.
18. Noland GS, Hendel-Paterson B, Min XM, et al. Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect Immun 2008;76:5721-8.
19. John CC, Riedesel MA, Magak NG, et al. Possible interruption of malaria transmission, highland Kenya, 2007-2008. Emerg Infect Dis 2009;15:1917-24.
20. Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol 2007;23:575-82.
21. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 2007;6:82.
22. Warren M, Collins WE, Jeffery GM, Skinner JC. The seroepidemiology of malaria in Middle America. II. Studies on the Pacific coast of Costa Rica. Am J Trop Med Hyg 1975;24:749-54.
23. Warren M, Collins WE, Cedillos R, Jeffery GM. The seroepidemiology of malaria in Middle America. III. Serologic assessment of localized Plasmodium falciparum epidemics. Am J Trop Med Hyg 1976;25:20-5.
24. Corran PH, Cook J, Lynch C, et al. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J 2008;7:195.
25. Schittek B, Rajewsky K. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature 1990;346:749-51.
26. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003;171:4969-73.
27. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998;8:363-72.
28. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005;23:367-86.
29. Wipasa J, Suphavilai C, Okell LC, et al. Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLOS Pathog 2010;6:e1000770.
30. Traggiai E, Puzone R, Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003;21(Suppl 2):S35-7.
31. Terstappen LW, Johnsen S, Segers-Nolten IM, Loken MR. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood 1990;76:1739-47.
32. Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998;10:252-8.
33. Pauli NT, Henry Dunand CJ, Wilson PC. Exploiting human memory B cell heterogeneity for improved vaccine efficacy. Front Immunol 2011;2:77.
34. Oracki SA, Walker JA, Hibbs ML, Corcoran LM, Tarlinton DM. Plasma cell development and survival. Immunol Rev 2010;237:140-59.
35. Amanna IJ, Slifka MK. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 2010;236:125-38.
36. Richards JS, Stanisic DI, Fowkes FJ, et al. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis 2010;51:e50-60.
37. Dodoo D, Hollingdale MR, Anum D, et al. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J 2011;10:168.
38. John CC, Tande AJ, Moormann AM, et al. Antibodies to preerythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis 2008;197:519-26.
39. Tran TM, Ongoiba A, Coursen J, et al. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. J Infect Dis 2014;209:789-98.